MedCap decides on share repurchase program
The board uses authorization to repurchase shares up to 25 MSEK on Nasdaq Stockholm to ensure LTIP 2026/2029 and adjust the capital structure.
See the latest news and media coverage for MedCap. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life science investment company
medcap.seLast updated
In short: MedCap reported strong financial growth for Q1 2026 and 2025, completed a share buyback program, and executed several strategic acquisitions.
The board uses authorization to repurchase shares up to 25 MSEK on Nasdaq Stockholm to ensure LTIP 2026/2029 and adjust the capital structure.
The meeting elected a new board with Karl Tobieson as chairman, approved LTIP 2026 with 200,000 options and authorized share buybacks and issuances.
Net sales increased 13% to 556.6 MSEK and EBITA rose 32% to 109.6 MSEK. All business areas grew.
The meeting is held at IVA in Stockholm at 4:00 p.m. Registration or postal voting no later than April 27. Proposals on incentive program, remuneration guidelines and authorizations.
Medcap, which is an investment company within pharmaceuticals and medical technology, reports a net profit of 55.7 million kronor for the first quarter...
Find the latest MedCap AB (61MA.DU) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get the latest MedCap AB (publ) (MCAP.ST) stock news and headlines to help you in your trading and investing decisions.
MedCap (OM:MCAP) reported revenue growth forecasts of 13.2% per year, significantly outpacing the Swedish market's projected 3.8% annual growth. While the company has delivered average...
Track MedCap and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to MedCap and other trending companies.